CDH1 and invasive breast carcinoma: The recent study revealed that E-cadherin functions as a survival factor in invasive breast cancer during nearly all phases of metastasis, which hints strategy to inhibit E-cadherin-mediated survival may have potential as a therapeutic approach (36).